A new gene therapy called AMT-130 has shown promising results in slowing the progression of Huntington’s disease, according to the latest results from a global clinical trial.
A new study of chronic fatigue syndrome reveals how women are more severely affected by the condition and tend to develop more severe symptoms over time.
Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.
Dr Nauf AlBendar, Doctor of Clinical Medicine & Founder of The Womb Effect, introduces spina bifida, the primary cause of foetal loss and substantial disabilities in newborns.
Tuberculosis is the second most infectious deadly disease after COVID-19, so why has it been met with political inertia? Vinny Wooding, Senior Parliamentary Advocacy Officer at RESULTS UK, discusses the burden of TB and the rapid action needed to address this global threat.
The vast majority of genetic diseases remains beyond possibilities of treatment with research continuing to be able to offer therapies to the affected patients.
The National Institutes of Health and Salk Institute researchers have made strides in understanding the molecular mechanisms behind HIV drug resistance mechanisms.
The immune system is the body’s natural defence against antigens such as bacteria and viruses, but in some cases, it can malfunction. We explore the prevalence of immune system disorders, the associated unmet medical needs, and therapeutic research.
Simone Schoenwaelder from Australia’s Heart Research Institute tells us about exciting advancements in stroke research and care that could dramatically improve clinical outcomes for patients.
Chronic liver diseases can have a detrimental impact on physical and mental health; we explore the underlying causes, symptoms, and treatment for primary biliary cholangitis.
Diabetes can pose significant implications for individuals’ mental and physical wellbeing. While new research shows promise in supporting diabetes management and care, many challenges still remain. We discussed these with Beyond Type 1’s content strategist Dr Liz Kopco.
New polio vaccines: Two groundbreaking oral polio vaccines (nOPVs) have been created by scientists at UCSF and the UK's National Institute of Biological Standards and Control (NIBSC).
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.
